Gordon Carl L 的 Form 4 申報
Kinnate Biopharma Inc.（KNTE），2023/5/2 申報
- 申報編號
- 0000947871-23-000516
- 申報時間
- 2023/5/2
- 交易日
- 2023/4/28-5/2
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 9 筆非衍生性交易。公開市場買進合計 $367.4 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gordon Carl LCIK 0001282930 | 董事、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/4/28 | Common Stock | P買進取得 | +60,998 | $2.55 | +$155,544.9 | 610,998 | 間接 | |
| 2023/4/28 | Common Stock | P買進取得 | +228,754 | $2.55 | +$583,322.7 | 3,737,784 | 間接 | |
| 2023/4/28 | Common Stock | P買進取得 | +60,997 | $2.55 | +$155,542.35 | 610,997 | 間接 | |
| 2023/5/1 | Common Stock | P買進取得 | +124,544 | $2.62F4 | +$326,305.28 | 735,542 | 間接 | |
| 2023/5/1 | Common Stock | P買進取得 | +467,068 | $2.62F4 | +$1,223,718.16 | 4,204,852 | 間接 | |
| 2023/5/1 | Common Stock | P買進取得 | +124,545 | $2.62F4 | +$326,307.9 | 735,542 | 間接 | |
| 2023/5/2 | Common Stock | P買進取得 | +58,826 | $2.67F5 | +$157,065.42 | 794,368 | 間接 | |
| 2023/5/2 | Common Stock | P買進取得 | +220,610 | $2.67F5 | +$589,028.7 | 4,425,462 | 間接 | |
| 2023/5/2 | Common Stock | P買進取得 | +58,826 | $2.67F5 | +$157,065.42 | 794,368 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F4
Represents the weighted average purchase price of the shares of common stock purchased, ranging from a low of $2.59 to a high of $2.64 per share. The Reporting Persons undertakes, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
表 I 有 3 筆交易的價格引用這則附註。
- F5
Represents the weighted average purchase price of the shares of common stock purchased, ranging from a low of $2.57 to a high of $2.82 per share. The Reporting Person undertakes, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
表 I 有 3 筆交易的價格引用這則附註。